Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 24 Apr 2023
Adding mint flavor to e-cigarette liquids increases the amount of vapour particles produced and is linked, according to a recent study published in Respiratory Research.
Read Full NewsResearchers seek to understand why Asian women fare better with the disease.
By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.
1.
In cases of metastatic or recurrent head and neck cancer, gene-guided immunotherapy falls short.
2.
Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target
3.
Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC
4.
An understudied type of breast cancer poses a lurking threat
5.
Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC
1.
Next-Gen Cancer Therapies: Radiopharmaceuticals, Immuno-Oncology, and Biologic Breakthroughs
2.
Seeing Beyond the Pink Ribbon: AI's New Battle Against Breast Cancer
3.
The Essential Guide to Understanding Fibrinogen and Its Role in Blood Clotting
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
The Future of Oncology: Innovations Every Doctor Should Know
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
3.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion
4.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge